Institutions Holding Call Options on Arbutus Biopharma Corp (ABUS)
This table provides information about the call option holders of Arbutus Biopharma Corp (ABUS). We have compiled data on the institutions that hold call options on the stock, with a total of 3.44 Million call options outstanding, which have been reported (via 13F filing form) to have a value of $13.6 Million at the end of the reported quarter. These call option holders have the right, but not the obligation, to buy AAPL shares at a specified price within a certain time frame.
| Holding | Report Date | calls Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Four World Capital Management LLC
New York, NY |
Aug 14, 2024 Q2 2024 |
1,570,000
calls
|
$6.19 Million
2.99% of portfolio
|
Q1 2024
New holding
|
|
|
Squarepoint Ops LLC
New York, NY |
Aug 14, 2024 Q2 2024 |
1,445,000
calls
|
$5.69 Million
0.01% of portfolio
|
Q1 2024
New holding
|
|
|
Citigroup Inc
|
Aug 12, 2024 Q2 2024 |
285,000
calls
|
$1.12 Million
0.0% of portfolio
|
N/A
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Aug 15, 2024 Q2 2024 |
117,000
calls
|
$460,980
0.0% of portfolio
|
N/A
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2024 Q2 2024 |
23,700
calls
|
$93,378
0.0% of portfolio
|
N/A
|